{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:55:10Z","timestamp":1782269710227,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007052","name":"Memorial Sloan Kettering Cancer Center","doi-asserted-by":"publisher","award":["P30 CA008748-50"],"award-info":[{"award-number":["P30 CA008748-50"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.prro.2018.10.015","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T22:29:57Z","timestamp":1542148197000},"page":"98-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus\u2013Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center"],"prefix":"10.1016","volume":"9","author":[{"given":"C. Jillian","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2018.10.015_bib1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.10.015_bib2","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/cncr.31338","article-title":"Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"124","author":"Chera","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.10.015_bib3","first-page":"6066","article-title":"OPTIMA-A phase 2 trial of induction chemotherapy response-stratified radiation therapy dose and volume de-escalation for HPV+ oropharyngeal cancer: Efficacy, toxicity, and HPV subtype analysis","volume":"35","author":"Seiwert","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib4","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1200\/JCO.2017.35.15_suppl.6076","article-title":"A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)","volume":"35","author":"Riaz","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.radonc.2017.03.003","article-title":"Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer","volume":"123","author":"Nevens","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oraloncology.2016.04.011","article-title":"Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT","volume":"58","author":"Gutiontov","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/COC.0000000000000064","article-title":"Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes","volume":"38","author":"Tam","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/lary.24907","article-title":"Level IB nodal involvement in oropharyngeal carcinoma: Implications for submandibular gland-sparing intensity-modulated radiotherapy","volume":"125","author":"Yu","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.prro.2018.10.015_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hed.23924","article-title":"Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance","volume":"38","author":"Mohindra","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.prro.2018.10.015_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/0284186X.2013.858825","article-title":"HPV-related oropharyngeal carcinoma with Overt Level II and\/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V","volume":"53","author":"Sanguineti","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib12","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2008.10.018","article-title":"Defining the risk of involvement for each neck nodal level in patients with early T-stage node-positive oropharyngeal carcinoma","volume":"74","author":"Sanguineti","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2018.10.015_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.prro.2016.11.002","article-title":"Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy","volume":"7","author":"Leeman","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib14","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1002\/cncr.28938","article-title":"Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life","volume":"120","author":"Spencer","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.10.015_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.prro.2017.02.002","article-title":"Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline","volume":"7","author":"Sher","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib16","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1200\/JCO.2017.73.8633","article-title":"Radiation therapy for oropharyngeal squamous cell carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline","volume":"35","author":"Quon","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.10.015_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2010.10.041","article-title":"Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: An update of the Memorial Sloan-Kettering Cancer Center experience","volume":"82","author":"Setton","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018303163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018303163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:21:20Z","timestamp":1761819680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850018303163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1879850018303163"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2018.10.015","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing the Radiation Therapy Dose Prescription for Elective Treatment Areas in Human Papillomavirus\u2013Associated Oropharyngeal Carcinoma Being Treated With Primary Chemoradiotherapy at Memorial Sloan Kettering Cancer Center","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.10.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.10.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}